RTX's Pratt & Whitney to provide affordable mass propulsion for Leidos' Small Cruise Missile program - RTX ( NYSE:RTX )
PARIS, June 16, 2025 /PRNewswire/ -- Pratt & Whitney, an RTX RTX business, has secured a contract from Dynetics, a Leidos company, to supply TJ150 engines to be integrated with their Small Cruise Missile, known as Black Arrow. The TJ150 is a compact, high performance turbojet engine that can be ...
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635 ( c ) ( 4 )
WATERTOWN, Mass., June 16, 2025 ( GLOBE NEWSWIRE ) -- EyePoint Pharmaceuticals, Inc. ( Nasdaq: EYPT ) , a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory ...
Crescent Biopharma Completes Closing of Merger with GlycoMimetics and Previously Announced Private Placement of $200 Million
Advancing Lead Program, CR-001, a PD-1 x VEGF Bispecific Antibody, and Developing Pipeline of Novel ADCs as Single Agents and in Combination with CR-001 On Track to Submit IND Application for CR-001 in Fourth Quarter of 2025 with Proof-of-Concept Clinical Data Expected in Second Half of 2026
Fury Finalizes Drill Targeting at its Newly Acquired Sakami Gold Project
TORONTO, June 16, 2025 ( GLOBE NEWSWIRE ) -- Fury Gold Mines Limited ( TSX and NYSE American: FURY ) ( "Fury" or the "Company" ) is pleased to announce that is has finalized a number of drill targets at the Sakami gold project located in the Eeyou Istchee Territory in the James Bay region of ...
Nokia announces changes to Group Leadership Team
Nokia Corporation Stock Exchange Release 16 June 2025 at 14:00 EEST Federico Guillén to retire from Nokia on 31 December 2025. He will step down as President of the Network Infrastructure ( NI ) business group and as a member of the Group Leadership Team on 30 June 2025.
BioCryst Presents New Data on the Long-term Efficacy and Safety of ORLADEYO® ( berotralstat ) Across all Ages at EAACI - BioCryst Pharma ( NASDAQ:BCRX )
RESEARCH TRIANGLE PARK, N.C., June 16, 2025 ( GLOBE NEWSWIRE ) -- BioCryst Pharmaceuticals, Inc. BCRX today announced new data on the long-term efficacy and safety of ORLADEYO® ( berotralstat ) for the prophylactic treatment of hereditary angioedema ( HAE ) in patients across all age groups.
iBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment - iBio ( NASDAQ:IBIO )
iBio nominates IBIO-610 as development candidate for its first-in-class Activin E antibody New study aims to evaluate the half-life of IBIO-610 in obese, elderly non-human primates ( NHP ) and assess early signs of efficacy on fat reduction and body composition
Guardian Capital Announces June 2025 Cash Distributions for Guardian Capital ETFs
TORONTO, June 16, 2025 ( GLOBE NEWSWIRE ) -- Guardian Capital LP ( the "Manager" ) announces the following regular cash distributions for the period ending June 30, 2025, in respect of the ETF series of the Guardian Capital funds listed below ( the "Guardian Capital ETFs" ) .
Roundhill Announces Distribution Calendar Changes: ETF Lineup to Offer Distributions Every Weekday - Roundhill ETF Trust Roundhill Bitcoin Covered Call Strategy ETF ( BATS:YBTC ) , Roundhill ETF Trust Roundhill Ether Covered Call Strategy ETF ( BATS:YETH )
YETH will seek to pay weekly distributions starting in July; YBTC and YETH will now trade ex-dividend each Wednesday and pay on Thursday.
Aquestive Therapeutics Announces FDA Acceptance of New Drug Application and PDUFA Date for Anaphylm™ for the Treatment of Severe Allergic Reactions - Aquestive Therapeutics ( NASDAQ:AQST )
FDA assigns PDUFA target action date of January 31, 2026 WARREN, N.J., June 16, 2025 ( GLOBE NEWSWIRE ) -- Aquestive Therapeutics, Inc. AQST ( "Aquestive" or the "Company" ) , a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative ...






